Results 11 to 20 of about 542,591 (214)

COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases [PDF]

open access: yesFrontiers in Medicine, 2022
ObjectivesCOVID-19 outcomes in population with systemic autoimmune diseases (SAD) remain poorly understood. The aim was to examine demographic and clinical factors associated with COVID-19 infection in people with rheumatic disease.MethodsTwo phases ...
Borja Del Carmelo Gracia   +7 more
doaj   +3 more sources

Dysbiosis and probiotic applications in autoimmune diseases [PDF]

open access: yes, 2022
Several evidence in animal models and humans pointed to the involvement of oral and intestinal dysbiosis in the development of autoimmune diseases. Dysbiosis is associated with decreased bacterial function and diversity, as well as decreased beneficial ...
Salis, Larissa Vedovato Vilela de [UNESP]   +7 more
core   +1 more source

Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases [PDF]

open access: yes, 2023
Autoimmune polyendocrine syndromes (APSs), also called autoimmune polyglandular syndromes, are a group of autoimmune diseases characterized by the co-occurrence of dysfunctions of several (at least two) endocrine glands.
Katarzyna Suchta   +3 more
core   +1 more source

Sensory Neuronopathy And Autoimmune Diseases. [PDF]

open access: yes, 2015
Sensory neuronopathies (SNs) are a specific subgroup of peripheral nervous system diseases characterized by primary degeneration of dorsal root ganglia and their projections.
Nucci, Anamarli   +3 more
core   +1 more source

Pervasive Sharing of Genetic Effects in Autoimmune Disease [PDF]

open access: yes, 2011
Genome-wide association (GWA) studies have identified numerous, replicable, genetic associations between common single nucleotide polymorphisms (SNPs) and risk of common autoimmune and inflammatory (immune-mediated) diseases, some of which are shared ...
Klareskog, Lars   +113 more
core   +1 more source

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation [PDF]

open access: yes, 2022
Although modern clinical management strategies have improved the outcome of paediatric patients with severe autoimmune and inflammatory diseases over recent decades, a proportion will experience ongoing or recurrent/relapsing disease activity despite ...
The EBMT Autoimmune Diseases (ADWP) and Paediatric Diseases (PDWP) Working Parties
core   +3 more sources

Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens

open access: yesMediators of Inflammation, 2017
Citrullinated peptides are used for measuring anticitrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA). Accumulation of citrullinated proteins in the inflamed synovium suggests that they may be good targets for inducing peripheral ...
Smadar Gertel   +7 more
doaj   +1 more source

Autoimmunity and Otolaryngology Diseases [PDF]

open access: yesJournal of Immunology Research, 2018
Many systemic autoimmune diseases have otolaryngology manifestations that could represent a diagnostic challenge for clinicians, as they often constitute an early sign of an otherwise asymptomatic autoimmune condition and may lead to delayed diagnosis and treatment.
Massimo Ralli   +4 more
openaire   +6 more sources

Parmacological aspect of autoimmune diseases [PDF]

open access: yes, 2023
This thesis deals with the available treatments for autoimmune diseases and presents the most recent developments in this field. It discussed are the challenges presented to clinicians when choosing the optimal treatment for the individual patient ...
Carmon, Avia
core  

Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases

open access: yesClinical Case Reports, 2023
Key Clinical Message The immunosuppressant agents should be considered earlier in the course of treatment with rituximab, possibly after the unfavorable response at first cycle of treatment, especially in male patients and those with high BMI.
Zeinab Aryanian   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy